{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:10:21Z","timestamp":1790518221984,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T00:00:00Z","timestamp":1627171200000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.phrs.2020.105089","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T11:56:26Z","timestamp":1594986986000},"page":"105089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"160","author":[{"given":"Iris","family":"Pujade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Perino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3615-148X","authenticated-orcid":false,"given":"Cl\u00e9ment","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Raschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-3779","authenticated-orcid":false,"given":"Milo","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14740\/cr560w","article-title":"Comparison of clopidogrel with prasugrel and ticagrelor in patients with acute coronary syndrome: clinical outcomes from the national cardiovascular database ACTION registry","volume":"8","author":"Khayata","year":"2017","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.phrs.2020.105089_bib0010","series-title":"European Medicines Agency","author":"Summary Of Opinion (Inititial Authorization)","year":"2010"},{"key":"10.1016\/j.phrs.2020.105089_bib0015","series-title":"Summary of Product Characteristics","author":"AstraZeneca","year":"2020"},{"issue":"20","key":"10.1016\/j.phrs.2020.105089_bib0020","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2020.105089_bib0025","series-title":"European Medicines Agency (EMA)","author":"European Public Assessment Report","year":"2015"},{"issue":"19","key":"10.1016\/j.phrs.2020.105089_bib0030","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"Cannon","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.phrs.2020.105089_bib0035","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2020.105089_bib0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2020.105089_bib0045","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.11.056","volume":"57","author":"Scirica","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2020.105089_bib0050","series-title":"Proceedings of the 9th International Workshop on Cardiac Arrhythmias (Venice, October 2-5","first-page":"683","article-title":"Cardiac arrhythmias 2005","author":"Raviele","year":"2006"},{"key":"10.1016\/j.phrs.2020.105089_bib0055","series-title":"European Medicines Agency (EMA)","author":"European Public Assessment Report","year":"2011"},{"issue":"43","key":"10.1016\/j.phrs.2020.105089_bib0060","doi-asserted-by":"crossref","first-page":"e12978","DOI":"10.1097\/MD.0000000000012978","article-title":"Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: a systematic review and meta-analysis (2007-2017)","volume":"97","author":"Guan","year":"2018","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.phrs.2020.105089_bib0065","first-page":"2452","article-title":"Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ. J. Off. J. Japanese Circ. Soc."},{"issue":"10","key":"10.1016\/j.phrs.2020.105089_bib0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcma.2016.02.010","article-title":"Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: a multicenter retrospective pilot study","volume":"79","author":"Chen","year":"2016","journal-title":"J. Chinese Med. Assoc. JCMA."},{"key":"10.1016\/j.phrs.2020.105089_bib0075","series-title":"Evidence Based Practice: PICO Method","year":"2018"},{"key":"10.1016\/j.phrs.2020.105089_bib0080","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.phrs.2020.105089_bib0085","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jth.13316","article-title":"Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry","volume":"14","author":"Alexopoulos","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.phrs.2020.105089_bib0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of clinical epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2020.105089_bib0095","first-page":"i157","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ (Clin. Res. ed)"},{"issue":"12","key":"10.1016\/j.phrs.2020.105089_bib0100","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/pds.3884","article-title":"Ticagrelor and bradycardia: a nested case-control study","volume":"24","author":"Turgeon","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.phrs.2020.105089_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","article-title":"Quantitative methods in the review of epidemiologic literature","volume":"9","author":"Greenland","year":"1987","journal-title":"Epidemiol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2307\/2534018","article-title":"Comparison of meta-analysis versus analysis of variance of individual patient data","volume":"54","author":"Olkin","year":"1998","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.phrs.2020.105089_bib0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"key":"10.1016\/j.phrs.2020.105089_bib0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clin. Res. ed)"},{"key":"10.1016\/j.phrs.2020.105089_bib0130","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2020.105089_bib0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clin. Res. ed)"},{"issue":"10","key":"10.1016\/j.phrs.2020.105089_bib0140","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.105089_bib0145","series-title":"Association of Ticagrelor vs Clopidogrel with Major Adverse Coronary Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention","author":"Turgeon","year":"2020"},{"issue":"14","key":"10.1016\/j.phrs.2020.105089_bib0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012078","article-title":"Safety and effectiveness of contemporary P2Y12 inhibitors in an east asian population with acute coronary syndrome: a nationwide population-based cohort study","volume":"8","author":"Yun","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.phrs.2020.105089_bib0155","first-page":"1377","article-title":"Outcomes among clopidogrel, prasugrel, and ticagrelor in ST-Elevation myocardial infarction patients who underwent primary percutaneous coronary intervention from the TOTAL trial","volume":"35","author":"Welsh","year":"2019","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12933-019-0882-5","article-title":"Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial","volume":"18","author":"Rosenson","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2020.105089_bib0165","article-title":"Efficacy and safety of clopidogrel, prasugrel and ticagrelor in ACS patients treated with PCI: a propensity score analysis of the RENAMI and BleeMACS registries","author":"Peyracchia","year":"2019","journal-title":"Am. J. cardiovasc. drugs: drugs, devices, other interventions"},{"issue":"23","key":"10.1016\/j.phrs.2020.105089_bib0170","doi-asserted-by":"crossref","first-page":"e012844","DOI":"10.1161\/JAHA.119.012844","article-title":"S.F. effects of crushed ticagrelor versus eptifibatide bolus plus clopidogrel in troponin-negative acute coronary syndrome patients undergoing percutaneous coronary intervention: a randomized clinical trial","volume":"8","author":"Marian","year":"2019","journal-title":"J. Am. heart assoc. [Internet]"},{"issue":"8","key":"10.1016\/j.phrs.2020.105089_bib0175","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00228-019-02687-0","article-title":"Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study)","volume":"75","author":"Liu","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40256-018-00318-0","article-title":"Efficacy and safety of ticagrelor compared with clopidogrel in patients with end-stage renal disease with acute myocardial infarction","volume":"19","author":"Lee","year":"2019","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2020.105089_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40256-019-00339-3","article-title":"Real-world data of prasugrel vs. Ticagrelor in acute myocardial infarction: results from the RENAMI registry","volume":"19","author":"De Filippo","year":"2019","journal-title":"Am. J. cardiovasc. drugs: drugs, devices, other interventions"},{"issue":"9","key":"10.1016\/j.phrs.2020.105089_bib0190","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/phar.2311","article-title":"Comparative effectiveness and safety of ticagrelor versus prasugrel in patients with acute coronary syndrome: a retrospective cohort analysis","volume":"39","author":"Dawwas","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40256-018-0302-3","article-title":"DAPT plus cilostazol is better than traditional DAPT or aspirin plus ticagrelor as elective PCI for intermediate-to-Highly complex cases: prospective, randomized, PRU-Based study in Taiwan","volume":"19","author":"Chen","year":"2019","journal-title":"Am. J. cardiovasc. drugs: drugs, devices, other interventions"},{"key":"10.1016\/j.phrs.2020.105089_bib0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2019.04.010","article-title":"The effect of ticagrelor based dual antiplatelet therapy on development of late left ventricular thrombus after acute anterior ST elevation myocardial infarction","volume":"287","author":"Alt\u0131nta\u015f","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"16","key":"10.1016\/j.phrs.2020.105089_bib0205","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial","volume":"319","author":"Zhao","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2020.105089_bib0210","article-title":"Antiplatelet effects of ticagrelor versus clopidogrel after coronary artery bypass graft surgery: a single-center randomized controlled trial","author":"Xu","year":"2018","journal-title":"J. thoracic cardiovasc. Surg. [Internet]."},{"issue":"4","key":"10.1016\/j.phrs.2020.105089_bib0215","first-page":"659","article-title":"Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: insights from the British Cardiovascular Intervention Society database","volume":"92","author":"Sirker","year":"2018","journal-title":"Catheterization cardiovasc. interventions Off. J. Soc. Cardiac Angiography Interventions"},{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1253\/circj.CJ-17-0632","article-title":"Cardiovascular and bleeding risks in acute myocardial infarction newly treated with ticagrelor vs. Clopidogrel in Taiwan","volume":"82","author":"Lee","year":"2018","journal-title":"Circulation J."},{"issue":"4","key":"10.1016\/j.phrs.2020.105089_bib0225","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ehj.2018.05.002","article-title":"Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: real world evidence","volume":"70","author":"Kumar","year":"2018","journal-title":"Egyptian heart J. (EHJ): Off. Bull. Egyptian Soc. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2020.105089_bib0230","doi-asserted-by":"crossref","first-page":"590","DOI":"10.20996\/1819-6446-2017-13-5-590-596","article-title":"Influence of switching of clopidogrel to ticagrelor on the development of cardiovascular events in patients with ST segment elevation myocardial infarction","volume":"13","author":"Tavlueva","year":"2017","journal-title":"Ration. Pharmacother. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/AC.71.3.3152091","article-title":"High-dose clopidogrel versus ticagrelor for treatment of acute coronary syndromes after percutaneous coronary intervention in CYP2C19 intermediate or poor metabolizers: a prospective, randomized, open-label, single-centre trial","volume":"71","author":"Zhang","year":"2016","journal-title":"Acta Cardiol."},{"issue":"6","key":"10.1016\/j.phrs.2020.105089_bib0240","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3892\/etm.2016.3224","article-title":"Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention","volume":"11","author":"Lu","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.phrs.2020.105089_bib0245","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/1076029614564208","article-title":"Efficacy of change to new P2Y12 receptor antagonists in patients high on treatment platelet reactivity undergoing percutaneous coronary intervention","volume":"21","author":"Robledo-Nolasco","year":"2015","journal-title":"Clin. Appl. Thromb."},{"issue":"4","key":"10.1016\/j.phrs.2020.105089_bib0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12928-014-0277-1","article-title":"Pharmacodynamics, pharmacokinetics and safety of ticagrelor in Asian patients with stable coronary artery disease","volume":"29","author":"Hiasa","year":"2014","journal-title":"Cardiovasc. Interv. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2020.105089_bib0255","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2710.2012.01367.x","article-title":"Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects","volume":"37","author":"Teng","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2020.105089_bib0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00228-009-0778-5","article-title":"Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects","volume":"66","author":"Teng","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2020.105089_bib0265","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5414\/CPP48643","article-title":"Single-dose ticagrelor does not prolong the QT interval in healthy subjects","volume":"48","author":"Butler","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2020.105089_bib0270","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur. Heart J."},{"issue":"29","key":"10.1016\/j.phrs.2020.105089_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurheartj\/ehz185","article-title":"Randomized trial of ticagrelor vs. Aspirin in patients after coronary artery bypass grafting: the TiCAB trial","volume":"40","author":"Schunkert","year":"2019","journal-title":"Eur. Heart J."},{"issue":"10204","key":"10.1016\/j.phrs.2020.105089_bib0280","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(19)31887-2","article-title":"Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial","volume":"394","author":"Bhatt","year":"2019","journal-title":"Lancet (London, England)."},{"issue":"22","key":"10.1016\/j.phrs.2020.105089_bib0285","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.jacc.2019.03.011","article-title":"Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis: TREAT trial","volume":"73","author":"Berwanger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2020.105089_bib0290","first-page":"2175","article-title":"CliX.N.iCal efficacy of ticagrelor in patients undergoing emergency intervention for acute myocardial infarction and its impact on platelet aggregation rate","volume":"10","author":"Wu","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.phrs.2020.105089_bib0295","article-title":"Efficacy and safety of ticagrelor in relation to prior aspirin usage in the SOCRATES trial","volume":"48","author":"Wong","year":"2017","journal-title":"Stroke Conference: american Heart Association\/american Stroke Association 2017 International Stroke Conference and State-of-the-Science Stroke Nursing Symposium United States [Internet]"},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0305","first-page":"1","article-title":"Comparison of ticagrelor and high-dose clopidogrel on the platelet functions in patients with inadequate response to clopidogrel","volume":"7","author":"Gu","year":"2017","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2020.105089_bib0310","first-page":"11831","article-title":"Safety and efficacy of ticagrelor with emergency percutaneous coronary intervention in senile patients with ST-segment elevation myocardial infarction and dementia","volume":"9","author":"Wang","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0315","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00059-015-4359-3","article-title":"Ticagrelor vs. Clopidogrel in non-ST-elevation acute coronary syndromes","volume":"41","author":"Ren","year":"2016","journal-title":"Herz"},{"key":"10.1016\/j.phrs.2020.105089_bib0320","first-page":"216","article-title":"High on-treatment after aspirin loading dose platelet reactivity as a modifiable risk factor to tailor antiplatelet therapy in acute coronary syndrome","volume":"5","author":"Malinova","year":"2016","journal-title":"European Heart Journal: Acute Cardiovascular Care Conference: Acute Cardiovascular Care 2016 Portugal Conference Start: 20161015 Conference End: 20161017 [Internet]"},{"key":"10.1016\/j.phrs.2020.105089_bib0325","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.105089_bib0330","series-title":"Evaluation of Bradycardia in the Emergency Department","author":"Murano","year":"2017"},{"issue":"suppl_2","key":"10.1016\/j.phrs.2020.105089_bib0335","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/europace\/eux258","article-title":"A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of cardiology countries: 2017 report from the European heart rhythm association","volume":"19","author":"Raatikainen","year":"2017","journal-title":"Europace: European pacing, arrhythmias, cardiac electrophysiol. J. working groups cardiac pacing, arrhythmias, cardiac cell. electrophysiol. European Soc. Cardiology"},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0340","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000177","article-title":"Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population","volume":"1","author":"Bradshaw","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.phrs.2020.105089_bib0345","series-title":"Stimulateurs Cardiaques Et Conventionnels: Place Respective Des Stimulateurs Simple Et Double Chambre Haute Autorit\u00e9 De Sant\u00e9 - Service Evaluation Des Dispositifs F\u00e9vrier","year":"2009"},{"key":"10.1016\/j.phrs.2020.105089_bib0350","series-title":"Analysing Data and Undertaking Meta-analyses: the Cochrane Collaboration","author":"Deeks","year":"2011"},{"issue":"3","key":"10.1016\/j.phrs.2020.105089_bib0355","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1152\/physrev.1990.70.3.761","article-title":"Cardiovascular purinoceptors","volume":"70","author":"Olsson","year":"1990","journal-title":"Physiol. Rev."},{"issue":"19","key":"10.1016\/j.phrs.2020.105089_bib0360","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2010.11.056","volume":"57","author":"Scirica","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.phrs.2020.105089_bib0365","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.hrcr.2018.07.017","article-title":"Cyclical sinus bradycardia and atrioventricular block induced by ticagrelor","volume":"4","author":"Waldmann","year":"2018","journal-title":"HeartRhythm Case Rep."},{"key":"10.1016\/j.phrs.2020.105089_bib0370","article-title":"A case of atrioventricular block potentially associated with right coronary artery lesion and ticagrelor therapy mediated by the increasing adenosine plasma concentration","volume":"2018","author":"Li","year":"2018","journal-title":"Case Rep. Vasc. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105089_bib0375","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0897190016680978","article-title":"Successful reversal of bradycardia and dyspnea with aminophylline after ticagrelor load","volume":"31","author":"Minner","year":"2018","journal-title":"J. Pharm. Pract."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820313979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820313979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:14:51Z","timestamp":1760912091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820313979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":75,"alternative-id":["S1043661820313979"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105089","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105089"}}